Primary care physicians accounted for around 30 percent of opioid and naloxone prescriptions in the U.S. in 2018. Naxolone is used to block the effects of opioids and is used to treat opioid overdose.
Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty*
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Number of opioid and naloxone prescriptions in the U.S. 2018, by prescriber specialty
- Basic Statistic Rate of naloxone prescriptions per 100 opioid prescriptions U.S. 2018, by prescriber
- Premium Statistic Physicians that received opioid-manufacturer payments in New York 2013-2015
- Premium Statistic Distribution of U.S. oncology practices by size and setting 2016
- Basic Statistic Number of oncology practices in the U.S. by region and size 2013
- Basic Statistic Most challenging parts of being a dermatologist in the U.S. as of 2020
- Basic Statistic Most rewarding parts of being a dermatologist in the U.S. as of 2020
- Premium Statistic Earnings of U.S. dermatologists as of 2020, by gender
- Basic Statistic Earnings of U.S. rheumatologists as of 2020, by gender
- Premium Statistic Earnings of U.S. pediatricians as of 2020, by gender
About the region
10
- Basic Statistic Fentanyl combination exhibits in U.S. 2015-2019
- Basic Statistic Rate of naloxone dispensing from retail pharmacies U.S. 2012-2018, by urbanization
- Premium Statistic Rate of naloxone dispensing from retail pharmacies U.S. 2012-2018, by region
- Premium Statistic High availability of heroin in U.S. 2010 and 2017, by region
- Basic Statistic Potential fentanyl profitability compared to heroin in the U.S. as of 2017
- Basic Statistic Consumption of opium alkaloids and derivatives by type U.S. 2014-2022
- Basic Statistic Colorado current active medical marijuana patients 2017-2022 by month
- Basic Statistic Colorado current marijuana patients by condition 2022
- Basic Statistic Tramadol out of pocket cost U.S. 2004-2021
- Basic Statistic Number of tramadol prescriptions in the U.S. 2004-2021
Other regions
10
- Basic Statistic Revenue of Alliance Pharma product brands 2022
- Basic Statistic Retail sales share for Rx oral solid opioids vs. all drugs, Canada 2017 by province
- Basic Statistic Express Scripts' revenue 2006-2017
- Premium Statistic Revenue of phytopharmaceuticals in Germany in 2022, by sales channel
- Premium Statistic Market capitalization of top local pharmaceutical companies in China Q1 2011
- Basic Statistic Reasons for visiting a community pharmacy in Great Britain 2014
- Premium Statistic Taisho Pharmaceutical's net income FY 2013-2020
- Premium Statistic Pharmacy sales volume in Italy 2021-2022, by segment
- Premium Statistic Market share of ethical and OTC drugs in Vietnam 2019-2022
- Premium Statistic Pharmaceutical sales in Argentina 2010-2021, by type
Related statistics
10
- Premium Statistic Visit rates for benzo and opioid prescriptions U.S. 2014-2016, by age and gender
- Basic Statistic Percentage of ED discharges with opioid prescriptions U.S. 2006 to 2017
- Basic Statistic Percentage of ED discharges with opioid prescriptions U.S. 2006-2017, by gender
- Premium Statistic Percentage of ED discharges with opioid prescriptions U.S. 2006 to 2017, by age
- Basic Statistic Percentage of ED discharges with opioid prescriptions U.S. 2006-2017, by ethnicity
- Basic Statistic Percentage of ED discharges with opioid prescriptions U.S. 2006-2017, by strength
- Premium Statistic Distribution of opioid prescriptions at ED discharge U.S. 2006-2017, by opioid type
- Basic Statistic Percentage of ED discharges with opioid prescriptions U.S. 2012 to 2017, by diagnosis
- Basic Statistic U.S. emergency department visits for nonfatal opioid overdoses, 2016-2017, by gender
- Basic Statistic U.S. emergency department visit rate for nonfatal opioid overdoses, 2016-2017, by age
Further related statistics
10
- M&A capacities - changes for the global pharma industry 2008-2015
- Sales of Johnson & Johnson 2006-2023 by region
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Global revenue share of EssilorLuxottica in 2022, by geographical area
- Sanofi's total assets 2007-2023
Further Content: You might find this interesting as well
Statistics
- M&A capacities - changes for the global pharma industry 2008-2015
- Sales of Johnson & Johnson 2006-2023 by region
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Global revenue share of EssilorLuxottica in 2022, by geographical area
- Sanofi's total assets 2007-2023
CDC, & MMWR. (August 9, 2019). Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty* [Graph]. In Statista. Retrieved April 28, 2024, from https://www.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/
CDC, und MMWR. "Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty* ." Chart. August 9, 2019. Statista. Accessed April 28, 2024. https://www.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/
CDC, MMWR. (2019). Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty* . Statista. Statista Inc.. Accessed: April 28, 2024. https://www.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/
CDC, and MMWR. "Distribution of Opioid and Naloxone Prescriptions Dispensed in The U.S. in 2018, by Prescriber Specialty* ." Statista, Statista Inc., 9 Aug 2019, https://www.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/
CDC & MMWR, Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty* Statista, https://www.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/ (last visited April 28, 2024)
Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty* [Graph], CDC, & MMWR, August 9, 2019. [Online]. Available: https://www.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/